investigated the efficacy and safety of the antimuscarinic tolterodine extended release (ER), the α 1-receptor antagonist tamsulosin, and a combination of both, in men with overactive bladder and ...
[25] The annual risk of death in 2009 was extracted for Greek men aged >50 years ... [24] Drug costs for tamsulosin and DUT + TAM FDC were based on the retail prices (Price Bulletin 15 ...